Metzger Michael A sold SNDX
February 9, 2026 · Form 4 insider transaction
Metzger Michael A sold 17,159 shares of Syndax Pharmaceuticals, Inc. at $21.03 per share, a transaction worth $360.8K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
17,159
Price
$21.03
Total value
$360.8K
InsiderMetzger Michael A
RoleOfficer, Director
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateFebruary 9, 2026
Filing dateFebruary 10, 2026
Shares owned after491,690
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units.